Lucas Rocha

Mirscience Therapeutics

He holds a degree in Nursing from the State University of Piauí and a PhD in Biomedical Sciences, with a specialization in Pharmacology, from the University of São Paulo (USP).

He has over 10 years of experience in research on non-coding RNAs (miRNA, lncRNA, and mRNA), with a focus on metabolic diseases, muscular disorders, and therapeutic development.

He is also an inventor, with contributions in the field of biotechnology applied to health innovation.

Since 2019, he has been the founder and CEO of Mirscience Therapeutics, a company dedicated to the development of RNA-based therapies.

He currently serves as Founder and CEO of Mirscience Therapeutics.